Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-109272

Chief Operating Officer gave up 1,428 shares (to pay taxes)

  • Chief Operating Officer acquired 2,813 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BILINSKY IGOR · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-14 Exercise or conversion : show line 1 in the form +2,813 57,235 D
2024-10-14 Shares withheld for taxes : show line 2 in the form −1,428 $9.77 $13,952 55,807 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-14 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,813 2,813 D
Loading xslF345X05/tm2426276-1_4seq1.xml…